Insider Trading Alert - Y, HWAY, MSCC, HCI And HCN Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Nov. 12, 2013, 237 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $100.00 to $356,344,136.36.

Highlighted Stocks Traded by Insiders:

Alleghany (Y) - FREE Research Report

Wong Raymond who is Director at Alleghany bought 300 shares at $390.21 on Nov. 12, 2013. Following this transaction, the Director owned 600 shares meaning that the stake was reduced by 100% with the 300 share transaction.

The shares most recently traded at $394.00, up $3.79, or 0.96% since the insider transaction. Historical insider transactions for Alleghany go as follows:

  • 12-Week # shares sold: 1,650
  • 24-Week # shares bought: 300
  • 24-Week # shares sold: 1,650

The average volume for Alleghany has been 42,000 shares per day over the past 30 days. Alleghany has a market cap of $6.6 billion and is part of the financial sector and insurance industry. Shares are up 17.37% year to date as of the close of trading on Tuesday.

Alleghany Corporation, together with its subsidiaries, engages in the property and casualty reinsurance and insurance business in the United States. It operates through two segments, reinsurance and insurance. The company has a P/E ratio of 22.4. Currently there are no analysts that rate Alleghany a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on Y - FREE

TheStreet Quant Ratings rates Alleghany as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Alleghany Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Healthways (HWAY) - FREE Research Report

Alison Taunton-Rigby who is Director at Healthways bought 4,100 shares at $12.13 on Nov. 12, 2013. Following this transaction, the Director owned 22,155 shares meaning that the stake was reduced by 22.71% with the 4,100 share transaction.

Tramuto Donato who is Director at Healthways bought 4,200 shares at $11.77 on Nov. 12, 2013. Following this transaction, the Director owned 4,200 shares meaning that the stake was reduced by 100% with the 4,200 share transaction.

The shares most recently traded at $12.35, up $0.58, or 4.7% since the insider transaction. Historical insider transactions for Healthways go as follows:

  • 4-Week # shares bought: 5,000
  • 12-Week # shares bought: 5,000
  • 24-Week # shares bought: 5,000

The average volume for Healthways has been 871,000 shares per day over the past 30 days. Healthways has a market cap of $427.7 million and is part of the health care sector and health services industry. Shares are up 14.02% year to date as of the close of trading on Tuesday.

Healthways, Inc., through its subsidiaries, provides specialized solutions to assist people to maintain and enhance their physical, emotional, and social well-being. Currently there are 4 analysts that rate Healthways a buy, 1 analyst rates it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HWAY - FREE

TheStreet Quant Ratings rates Healthways as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in stock price during the past year and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income, poor profit margins and feeble growth in the company's earnings per share. Get the full Healthways Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Microsemi (MSCC) - FREE Research Report

Pickle Paul H who is Executive Vice President at Microsemi sold 16,667 shares at $22.99 on Nov. 12, 2013. Following this transaction, the Executive Vice President owned 46,666 shares meaning that the stake was reduced by 26.32% with the 16,667 share transaction.

The shares most recently traded at $23.46, up $0.47, or 2.02% since the insider transaction. Historical insider transactions for Microsemi go as follows:

  • 4-Week # shares sold: 30,001
  • 12-Week # shares sold: 280,934
  • 24-Week # shares sold: 312,934

The average volume for Microsemi has been 494,300 shares per day over the past 30 days. Microsemi has a market cap of $2.2 billion and is part of the technology sector and electronics industry. Shares are up 10.46% year to date as of the close of trading on Tuesday.

Microsemi Corporation engages in the design, manufacture, and marketing of analog and mixed-signal integrated circuits (ICs) primarily in the United States, Europe, and Asia. The company has a P/E ratio of 11.9. Currently there are 4 analysts that rate Microsemi a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on MSCC - FREE

TheStreet Quant Ratings rates Microsemi as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Microsemi Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

HCI Group (HCI) - FREE Research Report

Patel Paresh who is Chief Executive Officer at HCI Group bought 356 shares at $43.80 on Nov. 12, 2013. Following this transaction, the Chief Executive Officer owned 34,000 shares meaning that the stake was reduced by 1.06% with the 356 share transaction.

The shares most recently traded at $45.07, up $1.27, or 2.82% since the insider transaction.

The average volume for HCI Group has been 189,500 shares per day over the past 30 days. HCI Group has a market cap of $497.5 million and is part of the financial sector and insurance industry. Shares are up 110.3% year to date as of the close of trading on Tuesday.

HCI Group, Inc. provides property and casualty insurance products in Florida. It operates through Insurance Operations and Other Operations segments. The company offers property and casualty insurance to homeowners, condominium owners, and tenants. The stock currently has a dividend yield of 2.54%. The company has a P/E ratio of 7.8. Currently there are 2 analysts that rate HCI Group a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on HCI - FREE

TheStreet Quant Ratings rates HCI Group as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, expanding profit margins and solid stock price performance. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full HCI Group Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Health Care REIT (HCN) - FREE Research Report

Herman Charles J Jr who is EVP & Chief Investment Officer at Health Care REIT sold 833 shares at $60.31 on Nov. 12, 2013. Following this transaction, the EVP & Chief Investment Officer owned 41,406 shares meaning that the stake was reduced by 1.97% with the 833 share transaction.

The shares most recently traded at $59.82, down $0.49, or 0.82% since the insider transaction. Historical insider transactions for Health Care REIT go as follows:

  • 4-Week # shares sold: 800
  • 12-Week # shares sold: 800
  • 24-Week # shares sold: 12,901

The average volume for Health Care REIT has been 1.7 million shares per day over the past 30 days. Health Care REIT has a market cap of $17.3 billion and is part of the financial sector and real estate industry. Shares are down 1.97% year to date as of the close of trading on Tuesday.

Health Care REIT, Inc. is an independent equity real estate investment trust. The firm engages in acquiring, planning, developing, managing, repositioning and monetizing of real estate assets. It primarily invests in the real estate markets of the United States. The stock currently has a dividend yield of 5.09%. The company has a P/E ratio of 82.3. Currently there are 5 analysts that rate Health Care REIT a buy, 2 analysts rate it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HCN - FREE

TheStreet Quant Ratings rates Health Care REIT as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and poor profit margins. Get the full Health Care REIT Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%